Literature DB >> 18756494

Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation.

Debbie Rybak1, Michael B Fallon, Michael J Krowka, Robert S Brown, Jenna Reinen, Linda Stadheim, Dorothy Faulk, Carrie Nielsen, Nadine Al-Naamani, Kari Roberts, Steven Zacks, Ted Perry, James Trotter, Steven M Kawut.   

Abstract

Chronic obstructive pulmonary disease (COPD) may cause significant symptoms and have an impact on survival. Smoking is an important risk factor for COPD and is common in candidates for liver transplantation; however, the risk factors for and outcomes of COPD in this population are unknown. We performed a prospective cohort study of 373 patients being evaluated for liver transplantation at 7 academic centers in the United States. COPD was characterized by expiratory airflow obstruction and defined as follows: prebronchodilator forced expiratory volume in 1 second/forced vital capacity < 0.70. Patients completed the Liver Disease Quality of Life Questionnaire 1.0, which included the Short Form-36. The mean age of the study sample was 53 +/- 9 years, and 234 (63%) were male. Sixty-seven patients (18%, 95% confidence interval 14%-22%) had COPD, and 224 (60%) had a history of smoking. Eighty percent of patients with airflow obstruction did not previously carry a diagnosis of COPD, and 27% were still actively smoking. Older age and any smoking (odds ratio = 3.74, 95% confidence interval 1.94-7.23, P < 0.001) were independent risk factors for COPD. Patients with COPD had worse New York Heart Association functional class and lower physical component summary scores on the 36-Item Short Form but had short-term survival similar to that of patients without COPD. In conclusion, COPD is common and often undiagnosed in candidates for liver transplantation. Older age and smoking are significant risk factors of COPD, which has adverse consequences on functional status and quality of life in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18756494      PMCID: PMC2823393          DOI: 10.1002/lt.21545

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  26 in total

1.  Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

Authors:  F Pessione; M J Ramond; C Njapoum; V Duchatelle; C Degott; S Erlinger; B Rueff; D C Valla; F Degos
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 2.  De novo malignancies after liver transplantation: a major cause of late death.

Authors:  J J Fung; A Jain; E J Kwak; S Kusne; I Dvorchik; B Eghtesad
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

3.  Health-related quality of life in chronic liver disease: the impact of type and severity of disease.

Authors:  Z M Younossi; N Boparai; L L Price; M L Kiwi; M McCormick; G Guyatt
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

Review 4.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

5.  Pulmonary gas exchange abnormalities in liver transplant candidates.

Authors:  Rosmawati Mohamed; Jonathan W Freeman; Peter J Guest; Michael K Davies; James M Neuberger
Journal:  Liver Transpl       Date:  2002-09       Impact factor: 5.799

6.  Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research.

Authors:  Shawna L Ehlers; James R Rodrigue; Michelle R Widows; Alan I Reed; David R Nelson
Journal:  Liver Transpl       Date:  2004-03       Impact factor: 5.799

7.  Smoking and hepatitis B-negative primary hepatocellular carcinoma.

Authors:  D Trichopoulos; B MacMahon; L Sparros; G Merikas
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

8.  Lung volumes in healthy nonsmoking adults.

Authors:  R O Crapo; A H Morris; P D Clayton; C R Nixon
Journal:  Bull Eur Physiopathol Respir       Date:  1982 May-Jun

9.  Standardized single breath normal values for carbon monoxide diffusing capacity.

Authors:  R O Crapo; A H Morris
Journal:  Am Rev Respir Dis       Date:  1981-02

10.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Earl S Ford; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-08-02
View more
  8 in total

1.  Smoking and Liver Disease.

Authors:  Stephanie M Rutledge; Amon Asgharpour
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

Review 2.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

Review 3.  [Hepatopulmonary interactions].

Authors:  V Fuhrmann; P Tariparast
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-08-06       Impact factor: 0.840

4.  [Anesthesiological aspects of liver transplantation].

Authors:  S Dehne; F Lund; J Larmann; K Schmidt; T Brenner; M A Weigand; R von Haken
Journal:  Anaesthesist       Date:  2019-06       Impact factor: 1.041

5.  MELD exceptions for portopulmonary hypertension: current policy and future implementation.

Authors:  D S Goldberg; S Batra; S Sahay; S M Kawut; M B Fallon
Journal:  Am J Transplant       Date:  2014-07-01       Impact factor: 8.086

6.  Evaluation of liver transplant candidates: A pulmonary perspective.

Authors:  Serife Savas Bozbas; Fusun Eyuboglu
Journal:  Ann Thorac Med       Date:  2011-07       Impact factor: 2.219

7.  National Trends In Kidney, Heart And Liver Transplants Among Patients With And Without Chronic Obstructive Pulmonary Disease In Spain (2001-2015).

Authors:  Javier de Miguel-Díez; Rodrigo Jiménez-García; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Ana López-de-Andres
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-26

Review 8.  The Emerging Clinical Significance of the Red Cell Distribution Width as a Biomarker in Chronic Obstructive Pulmonary Disease: A Systematic Review.

Authors:  Angelo Zinellu; Arduino A Mangoni
Journal:  J Clin Med       Date:  2022-09-25       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.